Search

SWG Educational Activities

2023 meetingsThe following EHA-SWG meetings took place in the past calendar year:

54th General Assembly of ERIC members at ELN Symposium 2023
Mannheim, Germany
April 18, 2023

ERIC/Brazilian CLL Group workshop on biomarkers in CLL
Brasilia, Brazil
May 25–26, 2023

55th General Assembly of ERIC members at…

Policy on life events

EHA has a policy on life events and eligibility. If you're submitting a grant application and the policy applies to your circumstances, you can ask us to extend the period of eligibility.

Policy on life events

EHA has a policy on life events and eligibility. If you're submitting a grant application and the policy applies to your circumstances, you can ask us to extend the period of eligibility.

Policy on life events

EHA has a policy on life events and eligibility. If you're submitting a grant application and the policy applies to your circumstances, you can ask us to extend the period of eligibility.

Breakthrough results in European multicenter trial on acute promyelocytic leukemia (APL): no more chemotherapy?

Dec 13 2012 Posted in Press releases

APL is a rare, yet aggressive, subtype of acute myeloid leukemia (AML) characterized by a maturation arrest of white blood cell precursors in the marrow, leading to a shortage of normal white cells and platelets in the blood, which is…

EHA2022 Gallery

Thank you to the Faculty, delegates, and industry partners for contributing to the EHA2022 Hybrid Congress.

EHA2024 gallery

Thank you to the esteemed faculty, delegates, and industry partners for their valuable contributions to the EHA2024 Hybrid Congress, which took place in Madrid and online from June 13–16.